Home > Insider Trading > Filing (0001209191-10-059990)

Filing Details

Accession Number:: 0001209191-10-059990
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-13 18:14:07
Reporting Period:: 2010-12-10

Filing Date:: 2010-12-13
Accepted Time:: 2010-12-13 18:14:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100962	Endo Pharmaceuticals Holdings Inc	ENDP	Pharmaceutical Preparations (2834)	134022871

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1034272	H Roger Kimmel	C/O Rothschild Inc. 1251 Avenue Of The Americas New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value, $.01 Per Share	Acquisiton	2010-12-10	1,250	$11.00	193,103	No	4	M	Direct
Common Stock, Par Value, $.01 Per Share	Acquisiton	2010-12-10	2,500	$11.05	195,603	No	4	M	Direct
Common Stock, Par Value, $.01 Per Share	Acquisiton	2010-12-10	9,991	$20.42	205,594	No	4	M	Direct
Common Stock, Par Value, $.01 Per Share	Disposition	2010-12-10	13,741	$36.55	191,853	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	2000 Stock Incentive Plan Stock Options (NQ)	Disposition	2010-12-10	1,250	$0.00	1,250	$11.00
Common Stock	2000 Stock Incentive Plan Stock Options (NQ)	Disposition	2010-12-10	2,500	$0.00	2,500	$11.05
Common Stock	2000 Stock Incentive Plan Stock Options (NQ)	Disposition	2010-12-10	9,991	$0.00	9,991	$20.42

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2012-03-12	No	4	M	Direct
2013-03-12	No	4	M	Direct
2014-03-12	No	4	M	Direct

Footnotes

This represents the average price at which Mr. Kimmel's common shares were sold at on December 10, 2010.
This number represents (i) 165,000 shares of common stock held in trusts for which Mr. Kimmel serves as trustee and as to which shares Mr. Kimmel holds either the sole or the shared power of disposition and power to vote, (ii) 2,262 shares of restricted stock, all of which are fully vested, (iii) 9,593 restricted stock units, of which 4,750 are fully vested and (iv) 14,998 shares of common stock, receipt of which has been deferred under the Endo Pharmaceuticals Directors Deferred Compensation Plan. Mr. Kimmel's beneficial ownership disclosed in this table excludes all shares held by Mr. Kimmel indirectly, including shares underlying stock options as well as a total of 7,500 shares of common stock held in trusts for the benefit of Mr. Kimmel's adult children, as to which shares Mr. Kimmel has neither the power of disposition nor the power to vote.
Mr. Kimmel's 5,000 non-qualified stock options granted under the 2000 Stock Incentive Plan on March 12, 2002, were generally exercisable 25% per year on each of March 12, 2003, March 12, 2004, March 12, 2005 and March 12, 2006.
Mr. Kimmel's 5,000 non-qualified stock options granted under the 2000 Stock Incentive Plan on March 12, 2003, were generally exercisable 25% per year on each of March 12, 2004, March 12, 2005, March 12, 2006 and March 12, 2007.
Mr. Kimmel's 10,000 non-qualified stock options granted under the 2000 Stock Incentive Plan on March 12, 2004, were generally exercisable 25% per year on each of March 12, 2005, March 12, 2006, March 12, 2007 and March 12, 2008.